Tykerb And Herceptin - Their Role In Breast Cancer Treatment Clarified

[News]

Patients with HER2-positive breast cancer have been treated with Tykerb (lapatinib) both in combination with herceptin (trastuzumab), and as an alternative single-agent therapy for pre-surgery (neo-adjuvant) chemotherapy...

More... (http://www.medicalnewstoday.com/articles/240518.php)